- Durability of a sustained virologic response in patients with chronic hepatitis C treated with peginterferon and ribavirin
-
Kim KA
- KMID: 1105520
- Korean J Hepatol.
- 2011 Mar;17(1):84-86.
- doi: 10.3350/kjhep.2011.17.1.84
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- IgG4-related sclerosing cholangitis: liver biopsy findings
-
Ryu HS, Kim H
- KMID: 1105518
- Korean J Hepatol.
- 2011 Mar;17(1):76-79.
- doi: 10.3350/kjhep.2011.17.1.76
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic amyloidosis
-
Shin YM
- KMID: 1105519
- Korean J Hepatol.
- 2011 Mar;17(1):80-83.
- doi: 10.3350/kjhep.2011.17.1.80
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Liver function tests as indicators of metabolic syndrome
-
Lee HC
- KMID: 1105508
- Korean J Hepatol.
- 2011 Mar;17(1):9-11.
- doi: 10.3350/kjhep.2011.17.1.9
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Three cases of amoebic liver abscess causing inferior vena cava obstruction, with a review of the literature
-
Sarda AK, Mittal R, Basra BK, Mishra A, Talwar N
- KMID: 1105517
- Korean J Hepatol.
- 2011 Mar;17(1):71-75.
- doi: 10.3350/kjhep.2011.17.1.71
Amoebic liver abscess is a common disease, especially in endemic areas, but it is a rare cause of inferior vena cava (IVC) obstruction, with only a few cases appearing in... -
- CITED
-
- Close
- SHARE
-
- Close
- Chronic hepatitis B in pregnancy: unique challenges and opportunities
-
Yogeswaran K, Fung SK
- KMID: 1105507
- Korean J Hepatol.
- 2011 Mar;17(1):1-8.
- doi: 10.3350/kjhep.2011.17.1.1
Chronic hepatitis B (CHB) affects 350 million individuals worldwide. Perinatal transmission leads to high rates of chronic infection and complications, including cirrhosis and hepatocellular carcinoma. It is important to recognize... -
- CITED
-
- Close
- SHARE
-
- Close
- Vogt-Koyanagi-Harada disease occurring during pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C
-
Lim JH, Lee YN, Kim YS, Kim SG, Jeong SW, Jang JY, Kim HS, Lee SH, Park TK
- KMID: 1105515
- Korean J Hepatol.
- 2011 Mar;17(1):61-65.
- doi: 10.3350/kjhep.2011.17.1.61
Vogt-Koyanagi-Harada (VKH) disease is a multisystem syndrome characterized by ocular (uveitis and retinal detachment), neurological (headache, tinnitus, and meningitis), and integumentary (vitiligo, alopecia, and poliosis) involvement. Although the pathogenesis of... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinicopathologic significance of the expression of Snail in hepatocellular carcinoma
-
Woo HY, Min AL, Choi JY, Bae SH, Yoon SK, Jung CK
- KMID: 1105509
- Korean J Hepatol.
- 2011 Mar;17(1):12-18.
- doi: 10.3350/kjhep.2011.17.1.12
BACKGROUND/AIMS: E-cadherin is involved in intercellular binding and cellular polarity formation. Snail is a key regulator of the epithelial-mesenchymal transition and is closely associated with tumor invasiveness due to its... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of pedunculated hepatic hemangioma mimicking submucosal tumor of the stomach
-
Moon HK, Kim HS, Heo GM, Shin WG, Kim KH, Jang MK, Lee JH, Kim HY, Kim DJ, Cho SJ
- KMID: 1105516
- Korean J Hepatol.
- 2011 Mar;17(1):66-70.
- doi: 10.3350/kjhep.2011.17.1.66
Hepatic hemangioma is the most common benign tumor of the liver. Most such hemangiomas are small, asymptomatic, and have an excellent prognosis. Giant hepatic hemangioma has been reported in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Genetic polymorphism at codon 10 of the transforming growth factor-beta1 gene in patients with alcoholic liver cirrhosis
-
Lee JJ, Park SK, Kwon OS, Won IS, Kim DK, Jung YK, Ku YS, Kim YS, Choi DJ, Kim JH
- KMID: 1105512
- Korean J Hepatol.
- 2011 Mar;17(1):37-43.
- doi: 10.3350/kjhep.2011.17.1.37
BACKGROUND/AIMS: Transforming growth factor beta1 (TGF-beta1) is a key cytokine in the production of extracellular matrix. A genetic polymorphism at codon 10 of the TGF-beta1 gene is associated with liver... -
- CITED
-
- Close
- SHARE
-
- Close
- Development and validation of a simple index system to predict nonalcoholic fatty liver disease
-
Park YJ, Lim JH, Kwon ER, Kim HK, Jung MC, Seol KH, Noh WY, Kim NE
- KMID: 1105510
- Korean J Hepatol.
- 2011 Mar;17(1):19-26.
- doi: 10.3350/kjhep.2011.17.1.19
BACKGROUND/AIMS: Abdominal ultrasonography is useful for the detection and diagnosis of nonalcoholic fatty liver disease (NAFLD). The aims of this study were to establish a predictive model for the selection... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of serum alanine aminotransferase and gamma-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease
-
Oh HJ, Kim TH, Sohn YW, Kim YS, Oh YR, Cho EY, Shim SY, Shin SR, Han AL, Yoon SJ, Kim HC
- KMID: 1105511
- Korean J Hepatol.
- 2011 Mar;17(1):27-36.
- doi: 10.3350/kjhep.2011.17.1.27
BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) has recently been found to be a novel component of metabolic syndrome (MS), which is one of the leading causes of chronic liver disease.... -
- CITED
-
- Close
- SHARE
-
- Close
- A nationwide seroprevalence of total antibody to hepatitis A virus from 2005 to 2009: age and area-adjusted prevalence rates
-
Lee D, Ki M, Lee A, Lee KR, Park HB, Kim CS, Yoon BY, Kim JH, Lee YS, Jeong SH
- KMID: 1105513
- Korean J Hepatol.
- 2011 Mar;17(1):44-50.
- doi: 10.3350/kjhep.2011.17.1.44
BACKGROUND/AIMS: Recent outbreak of hepatitis A in Korea is clearly related to the epidemiological shift of hepatitis A virus (HAV). However, nationwide seroprevalence data have been limited. This study estimated... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimal technique and response of doxorubicin beads in hepatocellular cancer: bead size and dose
-
Martin R, Irurzun J, Munchart J, Trofimov I, Scupchenko A, Tatum C, Narayanan
- KMID: 1105514
- Korean J Hepatol.
- 2011 Mar;17(1):51-60.
- doi: 10.3350/kjhep.2011.17.1.51
BACKGROUND/AIMS: It has been shown that the drug-eluting beads loaded with doxorubicin (DEBDOX) are effective for the treatment of hepatocellular carcinoma (HCC). However, the optimal safety and efficacy still remain... -
- CITED
-
- Close
- SHARE
-
- Close
